Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;13(1):20-24.
doi: 10.1016/j.joto.2017.10.001. Epub 2017 Oct 13.

Does the use of recombinant TSH in preparation for I-131 scintigraphy scan affect hearing function?

Affiliations

Does the use of recombinant TSH in preparation for I-131 scintigraphy scan affect hearing function?

Mehtap Doğan et al. J Otol. 2018 Mar.

Abstract

Objective: The objective of this study was to examine the effect of hypothyroidism on hearing function in patients surgically treated for differentiated thyroid cancer and subsequently experienced hypothyroidism during preparation for follow up I-131 scintigraphy scan by either recombinant human thyroid stimulating hormone (rhTSH) treatment or thyroid hormone withdrawal (THW).

Methods: A total of 55 patients undergoing I-131 scintigraphy scan following surgeries for differentiated thyroid cancer were included in the study, including 25 patients prepared by administration of recombinant TSH (rhTSH Group) and 30 patients by thyroid hormone withdrawal (THW Group).

Results: Air conduction thresholds at 1, 2 and 4 kHz for both ears were higher during hypothyroid period than during euthyroid period for patients in the THW group (p < 0.05) but not for patients in the rhTSH group.

Conclusion: Sensorineural hearing loss was detected, especially at low frequencies, in patients with DTC after surgical treatment whose hormone replacement therapy was withdrawn but not in those receiving rhTSH. It is therefore preferred to use rhTSH when preparing for I-131 scintigraphy scan in patients at risk for hearing loss.

Keywords: Hearing loss; Radioiodine; Recombinant TSH; Thyroid hormone withdrawal.

PubMed Disclaimer

Similar articles

References

    1. Al Balooshi B., Vinjamuri S. Should all patients with differentiated thyroid carcinoma undergo 131I SPECT-CT scanning rather than 131I whole-body scanning? Nucl. Med. Commun. 2015;36(6):549–552. PubMed PMID: 25906202. - PubMed
    1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Pacini F., Schlumberger M., Sherman S.I., Steward D.L., Tuttle R.M. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–1214. - PubMed
    1. Bhatia P.L., Gupta O.P., Agrawal M.K. Audiological and vestibular function test in hypothyroidism. Laryngoscope. 1977;87:2082–2089. - PubMed
    1. Bircher H. Der endemische Kropf und seine Beziehun- gen zur Taubstummheit und zum Kretinismus (Endemic Goitre in Relation to Deaf-mut Kemp WR (1907) Deafness in myxoedema. Br. Med. J. 1883;(1):375.
    1. Buck A.K., Nekolla S., Ziegler S., Beer A., Krause B.J., Herrmann K. SPECT/CT. JNM. 2008;49:1305–1319. - PubMed

LinkOut - more resources